Success Story: Advancing Data-Driven Healthcare Decisions Through Real-World Evidence Research: NIW Approval Secured for a Health Services Researcher from China

Client’s Testimonial:

 

“I’m very grateful to the team for helping me successfully navigate the NIW process. They developed a strong overall strategy for my case and were thoughtful in presenting my research background and proposed endeavor. I especially appreciated the guidance and support throughout the process, and I’m very happy that my petition was approved. Thank you to the team for helping me reach this important milestone.”

 


 

On September 3rd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Consultant in the field of Health Services Research (Approval Notice).

 


 

General Field: Health Services Research

 

Position at the Time of Case Filing: Senior Consultant

 

Country of Origin: China

 

State of Residence at the Time of Filing: Massachusetts

 

Approval Notice Date: September 3rd, 2026

 

Processing Time: 28 days (Premium Processing Requested)

 


 

Case Summary:

 

We are pleased to share the NIW approval of a health services researcher whose work advances evidence-based healthcare decision-making through real-world evidence generation. The client’s proposed endeavor focuses on analyzing large-scale healthcare and survey data to evaluate treatment effectiveness, healthcare outcomes, economic impacts, care gaps, and healthcare disparities in high-burden diseases to inform clinical guidelines and public health policies.

 

At the time of filing, the client was working as a Senior Consultant, where she applied expertise in health economics, outcomes research, and healthcare data analysis to generate actionable evidence for improving healthcare delivery.

 

Research with National Importance

 

The client’s research addresses critical healthcare challenges by translating complex real-world data into evidence that supports treatment decisions, resource allocation, public health preparedness, and health equity initiatives. Her work has evaluated treatment patterns, healthcare resource utilization, vaccine uptake, and disparities across diverse patient populations, aligning with U.S. priorities in healthcare innovation, public health, and value-based care.

 

Academic Contributions and Recognition

 

At the time of filing, the client had authored 14 peer-reviewed journal articles (1 first-authored) and 17 abstracts (1 first-authored). Her published work received 80 citations, demonstrating recognition from researchers studying healthcare outcomes, treatment effectiveness, health economics, and real-world evidence generation.

 

Her publications appeared in highly regarded journals, including Journal of Headache and Pain, Expert Review of Vaccines, Annals of Allergy, Asthma & Immunology, Cancers, The Journal of Arthroplasty, and PLOS ONE. Five of her publications ranked among the top 10% most cited articles in Clinical Medicine for their respective years of publication. She has also completed at least 11 peer reviews for respected journals, including BMC Cancer, BMC Medicine, and Health Affairs Scholar, reflecting recognition of her expertise by the research community.

 

Expert Endorsements

 

Experts highlighted the client’s contributions to advancing real-world evidence generation and improving healthcare decision-making.

 

One expert noted:

 

“Ultimately, her ongoing efforts to generate real-world evidence and translate complex data into actionable strategies are vital for shaping national health policies and advancing equitable healthcare delivery across the United States.”

 

This endorsement reinforces the significance of the client’s contributions to health services research. Combined with her publication record, citation impact, peer review activities, and research influence, the expert recognition further demonstrates her ability to advance data-driven healthcare strategies and inform evidence-based policies.

 

NIW Approval and Outlook

 

The I-140 NIW petition was filed on August 6th, 2026, with Direct Premium Processing, and approved on September 3rd, 2026. The approval recognized the national importance of the client’s work in health services research, particularly her efforts to translate large-scale healthcare data into evidence that supports clinical decision-making and national health policies.

 

This outcome supports the client’s continued efforts to advance real-world evidence research, healthcare policy development, and data-driven approaches for improving healthcare outcomes in the United States. We congratulate her on this approval and wish her continued success in advancing health services research.